ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

RNAZ TransCode Therapeutics Inc

0.7251
-0.005 (-0.68%)
最終更新日: 22:34:01
15分遅延
名称 銘柄コード 市場 種別
TransCode Therapeutics Inc RNAZ NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.005 -0.68% 0.7251 22:34:01
始値 安値 高値 終値 前日終値
0.73 0.7002 0.73 0.7301
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1406:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1321:30GLOBETransCode Therapeutics Open Letter to Shareholders
2024/5/1105:50EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/5/1105:45EDGAR2Form 8-K - Current report
2024/4/1522:00GLOBETransCode Therapeutics Announces FDA Clearance To Initiate..
2024/4/0322:10GLOBETransCode Therapeutics Reports 2023 Results; Provides..
2024/3/2821:30GLOBETransCode Therapeutics Announces Appointment of Daniel..
2024/3/1122:00GLOBETransCode Therapeutics and Akribion Genomics Report Progress..
2024/3/0706:15GLOBETransCode Therapeutics To Present At 2024 RNA Leaders Europe..
2024/2/2022:00GLOBETransCode Therapeutics Reports Publication of United States..
2024/2/1606:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1410:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0106:33EDGAR2Form 8-K - Current report
2024/2/0106:05GLOBENasdaq Determines TransCode Therapeutics Compliance with..
2024/1/2922:30GLOBETransCode Therapeutics and Debiopharm Announce Collaboration..
2024/1/2306:45EDGAR2Form 8-K - Current report
2024/1/2306:45GLOBETransCode Therapeutics Announces Closing of $7.25 Million..
2024/1/2011:57EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/1/1914:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/1903:27GLOBETransCode Therapeutics Announces Pricing of $7.25 Million..
2024/1/1900:39EDGAR2Form S-1/A - General form for registration of securities..
2024/1/1721:06EDGAR2Form S-1/A - General form for registration of securities..
2024/1/1706:01EDGAR2Form 8-K - Current report
2024/1/1306:05GLOBETransCode Therapeutics Reports Further Restructuring to..
2024/1/1122:22EDGAR2Form S-1 - General form for registration of securities under..
2024/1/1122:00GLOBETransCode Therapeutics Announces 1-for-40 Reverse Stock..
2024/1/0906:01EDGAR2Form 8-K - Current report
2024/1/0502:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/0422:05GLOBETransCode Therapeutics Publishes Open Letter Outlining..
2023/12/1906:28EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/1222:30GLOBETransCode Therapeutics Reports Positive Pre-Clinical Results..
2023/12/0906:57EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/12/0906:56EDGAR2Form 8-K - Current report
2023/12/0806:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/0523:00GLOBETransCode Therapeutics To Present Phase 0 Data at 2023 San..
2023/12/0507:07EDGAR2Form 8-K - Current report
2023/12/0506:10GLOBETransCode Therapeutics Announces Closing of $1.2 Million..
2023/12/0207:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0104:53GLOBETransCode Therapeutics Announces $1.2 Million Registered..
2023/11/1506:40EDGAR2Form 8-K - Current report
2023/11/1506:30GLOBETransCode Therapeutics Reports Third Quarter 2023 Results;..
2023/11/1006:13EDGAR2Form 8-K - Current report
2023/11/0111:20APSBiotech Shares Bid Up Following Public Offering Cancellation
2023/10/3105:33GLOBETransCode Therapeutics Withdraws Public Offering
2023/10/2805:06EDGAR2Form 8-K - Current report
2023/10/2721:00GLOBENasdaq Panel Grants TransCode Therapeutics Extension for..
2023/10/2705:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/2705:19GLOBETransCode Therapeutics Announces Public Offering of Common..
2023/10/2621:00GLOBETransCode Therapeutics Announces Prolonged Survival in..
2023/10/2421:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock